Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound florfenicol powder for treating mycoplasma of pigeon and preparation method thereof

A technology of compound florfenicol and florfenicol, applied in medical preparations containing active ingredients, antibacterial drugs, pharmaceutical formulas, etc., can solve problems such as inability to treat symptoms, slow recovery of pigeons, failure of pathogenic treatment, etc. Achieve the effects of reducing treatment failure rate, speeding up recovery, preventing and treating bacterial secondary infection

Inactive Publication Date: 2010-03-31
TIANJIN SHENGJI GRP CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The commonly used drugs for the treatment of pigeon microplasmosis are florfenicol powder, oxytetracycline powder, etc., because florfenicol and oxytetracycline powder are usually used alone, often produce drug resistance, making the pathogen insensitive to it The failure of the treatment, coupled with the inability to perform symptomatic treatment of the clinical symptoms of the pigeons, prolongs the treatment time and increases the dosage, slows down the recovery of the pigeons, affects the recovery, and often fails during the treatment process.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] (1) Pass florfenicol, oxytetracycline, atropine sulfate, doxofylline, and anhydrous glucose through an 80-mesh sieve respectively, and set aside.

[0019] (2) Take by weighing 2kg of sieved florfenicol, 12kg of oxytetracycline, 0.5kg of atropine sulfate, 0.2kg of doxofylline and fully mix them in a V-shaped mixer;

[0020] (3) Add 85.3kg of sieved anhydrous glucose into the mixture of above-mentioned florfenicol, oxytetracycline, atropine sulfate, doxofylline, fully mix in common mixer, discharge, cross 80 Mesh sieve obtains the compound recipe florfenicol powder for the treatment of pigeon microplasmosis of the present invention.

Embodiment 2

[0022] (1) Pass florfenicol, oxytetracycline, atropine sulfate, doxofylline, and anhydrous glucose through an 80-mesh sieve respectively, and set aside.

[0023] (2) Weigh 10 kg of sieved florfenicol, 2 kg of oxytetracycline, 0.05 kg of atropine sulfate, and 1.5 kg of doxofylline and fully mix them in a V-shaped mixer.

[0024] (3) Add 86.45 kg of sieved anhydrous glucose into the mixture of the above-mentioned florfenicol, oxytetracycline, atropine sulfate, doxofylline, fully mix in a common mixer, discharge, pass 80 Mesh sieve obtains the compound recipe florfenicol powder for the treatment of pigeon microplasmosis of the present invention.

Embodiment 3

[0026] (1) Pass florfenicol, oxytetracycline, atropine sulfate, doxofylline, and anhydrous glucose through an 80-mesh sieve respectively, and set aside.

[0027] (2) Weigh 3 kg of sieved florfenicol, 7 kg of oxytetracycline, 0.07 kg of atropine sulfate, and 1 kg of doxofylline and fully mix them in a V-shaped mixer.

[0028] (3) Add the sieved anhydrous glucose 88.93 to the mixture of the above-mentioned florfenicol, oxytetracycline, atropine sulfate, doxofylline, fully mix in a common mixer, discharge, pass through 80 mesh The compound florfenicol powder for the treatment of pigeon microplasmosis of the present invention is obtained by sieving.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a compound florfenicol powder for treating mycoplasma of pigeon and a preparation method thereof, and the objective of the invention is to provide a compound florfenicol powder, which has instant effect for treating ycoplasma of pigeon and has effect for secondary infection of bacteria, and a preparation method which is simple and easy to be realized. Florfenicol in powderis 2-10 wt%, oxytetracycline is 2-12%, atropine sulfate is 0.05-0.5%, doxofylline 0.2-1.5%, and the rest is anhydrous dextrose. Florfenicol and oxytetracycline kill pathogen, which reduces probabilityof drug tolerance; atropine sulfate controls secretion of the digestive tract gland; doxofylline suppresses cough and calms panting. The four ingredients use together has a combination and cooperation function, and can quickly treat disease against clinical symptoms of mycoplasma disease of pigeon and accelerate recovery of pigeon, and has the efficacies for seeking both temporary and permanent solution, simultaneously preventing and treating other bacteria secondary infections, reducing drug tolerance probability, and considerably improving cure rate.

Description

technical field [0001] The invention relates to a compound florfenicol powder for treating pigeon microplasmosis and a preparation method thereof. Background technique [0002] Pigeon microplasmosis is a unique disease of pigeons. It is a disease caused by pigeon microplasma. Microplasma is also called mycoplasma or mycoplasma. The main lesions occur in the respiratory tract of pigeons, so it is also called Chronic respiratory disease in pigeons. When pigeons develop microplasmosis, they manifest as cough, runny nose, and breathing sound. When the condition is severe, mouth breathing occurs, food intake is significantly reduced, and soil brown sticky loose stools are pulled. When the dead pigeon was dissected, it was found that viscous white exudates were visible to the naked eye in the trachea, throat, nasal cavity, and air sacs, the mucosa in the air sacs was thickened, and there was a caseous exudate in the air sacs. [0003] The commonly used drugs for the treatment of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/65A61K31/165A61K31/46A61P31/04A61P11/00
Inventor 徐克福
Owner TIANJIN SHENGJI GRP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products